Polypeptide. No CYP-interactions.

(To be edited, initial data ST OCT 04) Fab-fragment of the chimeric monoclonal antibody 7E3, binds to and blocks a platelet surface receptor. Used together with ASA and heparin as i.v. infusion 0.25 mg/kg BW, in percutaneous coronary intervention.